New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - felypressin 0.54 µg/ml; prilocaine hydrochloride 3% (30mg/ml.);   - solution for injection - active: felypressin 0.54 µg/ml prilocaine hydrochloride 3% (30mg/ml.)   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - infiltration anaesthesia in dentistry, where there is no need for profound ischaemia in the injected area.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - felypressin; prilocaine hydrochloride - solution for injection - 3 %w/v +0.54 microgram(s)/millilitre - amides; prilocaine, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.03 iu/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide; sodium acetate; chlorobutanol hemihydrate; acetic acid - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - felypressin; prilocaine hydrochloride -

Singapore - English - HSA (Health Sciences Authority)

dentsply (singapore) pte. ltd. - felypressin; prilocaine hcl - injection - 0.066 iu/2.2 ml - felypressin 0.066 iu/2.2 ml; prilocaine hcl 66 mg/2.2 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.03 iu/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; acetic acid; sodium acetate; chlorobutanol hemihydrate; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply limited - prilocaine hydrochloride felypressin - solution for injection - %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply limited - prilocaine hydrochloride felypressin - solution for injection